All Stories

  1. Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients

    Article • PharmacoEconomics - Open, August 2025, Springer Science + Business Media

    Ms Silvia Fenix-Caballero

  2. Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

    Article • The European Journal of Health Economics, April 2024, Springer Science + Business Media

    Ms Silvia Fenix-Caballero

  3. Response to the letter to the editor

    Article • The Breast, December 2021, Elsevier

    Ms Silvia Fenix-Caballero

  4. Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses

    Article • Journal of Oncology Pharmacy Practice, November 2021, SAGE Publications

    Ms Silvia Fenix-Caballero

  5. Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain

    Article • The Breast, August 2021, Elsevier

    Ms Silvia Fenix-Caballero

  6. Analysis of Overall Survival Benefit of Abemaciclib Plus Fulvestrant in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer

    Article • JAMA Oncology, July 2020, American Medical Association (AMA)

    Ms Silvia Fenix-Caballero

  7. Network meta‐analysis of first‐line treatments in transplant‐ineligible multiple myeloma patients

    Article • European Journal Of Haematology, March 2020, Wiley

    Ms Silvia Fenix-Caballero

  8. Checklist for clinical applicability of subgroup analysis

    Article • Journal of Clinical Pharmacy and Therapeutics, December 2019, Wiley

    Ms Silvia Fenix-Caballero

  9. Network meta‐analysis of tofacitinib versus biologic treatments in moderate‐to‐severe rheumatoid arthritis patients

    Article • Journal of Clinical Pharmacy and Therapeutics, February 2019, Wiley

    Ms Silvia Fenix-Caballero

  10. Pembrolizumab plus Chemotherapy in Lung Cancer

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2018, New England Journal of Medicine (NEJM/MMS)

    Ms Silvia Fenix-Caballero

  11. Píldora poscoital: un debate científico necesario

    Article • September 2016, Elsevier

    Ms Silvia Fenix-Caballero

  12. Graphic method to estimate overall survival benefit.

    Article • Journal of Clinical Pharmacy and Therapeutics, December 2015, Wiley

    Ms Silvia Fenix-Caballero

  13. Evaluación y posicionamiento de medicamentos como alternativas terapéuticas equivalentes

    Article • July 2014, Elsevier

    Ms Silvia Fenix-Caballero

  14. CP-058 Efficiency of a protocol to prevent delayed chemotherapy-induced emesis: Abstract CP-58 Table 1

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Ms Silvia Fenix-Caballero

  15. DI-012 Effectiveness and safety of triple therapy in the treatment of hepatitis C: Abstract DI-012 Table 1

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Ms Silvia Fenix-Caballero

  16. DI-026 Overall survival benefit with pomalidomide: area under curves-based reanalysis: Abstract DI-026 Table 1

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Ms Silvia Fenix-Caballero

  17. DI-037 Comparison of indirect treatment for first-line metastatic pancreatic cancer: Abstract DI-037 Table 1

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Ms Silvia Fenix-Caballero

  18. GM-006 Compliance with FDA recommendations about overdosing with carboplatin: Abstract GM-006 Table 1

    Article • European Journal of Hospital Pharmacy, February 2014, BMJ

    Ms Silvia Fenix-Caballero

  19. Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis

    Article • Journal of Clinical Pharmacy and Therapeutics, April 2013, Hindawi Publishing Corporation

    Ms Silvia Fenix-Caballero

  20. CPC-023 Assessment of the Whole Interceptive and Post-Fertilisation Effects of Postcoital Levonorgestrel

    Article • European Journal of Hospital Pharmacy, March 2013, BMJ

    Ms Silvia Fenix-Caballero

  21. CPC-122 Risk Factors in the Incidence of Chemotherapy-Induced Emesis: Abstract CPC-122 Table 1

    Article • European Journal of Hospital Pharmacy, March 2013, BMJ

    Ms Silvia Fenix-Caballero

  22. GRP-039 Classification of the Pharmaceutical Interventions Made Using the ISOFAR Programme

    Article • European Journal of Hospital Pharmacy, March 2013, BMJ

    Ms Silvia Fenix-Caballero

  23. GRP-181 The Clinical Impact of Calcium-Ceftriaxone Interaction in Patients on Total Parenteral Nutrition

    Article • European Journal of Hospital Pharmacy, March 2013, BMJ

    Ms Silvia Fenix-Caballero